共查询到13条相似文献,搜索用时 15 毫秒
1.
Summary 2-Halogeno- and 2-methyl-ethanols inhibit-chymotrypsin in the order of their substituted groups: [1] tri>di->mono-, [2] Br->Cl->CH3->F-. The inhibition by the halogeno-ethanols is mediated differently from that by the methyl-ethanols, ethanol, and urea. 相似文献
2.
Summary Silybin significantly antagonises the lethal poisoning of mice with -amanitine or phalloidine. In the same test, taxifolin, coniferyl alcohol, fisetin and (+)-catechin were not effective. 相似文献
3.
4.
C. Agostini M. Secchi D. Venturelli 《Cellular and molecular life sciences : CMLS》1980,36(9):1067-1068
Summary 5-Nucleotidase activity, an enzyme marker of the plasma membranes, increases in female rat liver homogenates following ethionine administration, while homogenates from males show no changes. Treatment with CCl4, colchicine, cycloheximide, emetine, ethanol and 5-fluorotryptophan does not significantly modify the 5-nucleotidase activity of liver homogenates of either female or male rats. 相似文献
5.
B. J. Clarris 《Cellular and molecular life sciences : CMLS》1982,38(3):350-351
Summary In medium supplemented with serum, PGE1 and PGE2 were equally potent in inducing cells with a fenestrated appearance, whereas PGF2 was comparatively ineffective. In BSA without serum the effects were more persistent and characterized by a high proportion of astrocyte-like cells. The effects were reversed upon removal of the prostaglandins.This work was supported by the National Health and Medical Research Council of Australia. 相似文献
6.
7.
Bartolomé F de Las Cuevas N Muñoz U Bermejo F Martín-Requero A 《Cellular and molecular life sciences : CMLS》2007,64(11):1437-1448
We have analyzed the intracellular signals that allow lymphoblasts from Alzheimer’s disease (AD) patients to escape from serum
deprivation-induced apoptosis. The following observations suggested that modulation of ERK1/2 activity by Ca2+/calmodulin (CaM) is involved in preventing apoptosis: (i) ERK1/2 activity seems to support lethality in control cells, as
PD98059, the inhibitor of the activating MEK prevented cell death; (ii) control cells show a persistent and higher stimulation
of ERK1/2 than that of AD cells in the absence of serum; (iii) CaM antagonists have no effects on control cells, but sensitize
AD cells to death induced by serum withdrawal and increased ERK1/2 phosphorylation, and (iv) no apoptotic effects of CaM antagonists
were observed in AD cells treated with PD98059. These results suggest the existence of an activation threshold of the ERK1/2
pathway setting by Ca2+/CaM-dependent mechanisms, which appears to be the critical factor controlling cell survival or death decision under trophic
factor withdrawal.
F. Bartolomé, N. de las Cuevas: These authors contributed equally to this work.
Received 14 February 2007; received after revision 16 April 2007; accepted 23 April 2007 相似文献
8.
Tang J Wu YM Zhao P Yang XM Jiang JL Chen ZN 《Cellular and molecular life sciences : CMLS》2008,65(18):2933-2942
Mechanism of HAb18G/CD147 underlying the metastasis process of human hepatoma cells has not been determined. In the present
study, we found that integrin α3β1 colocalizes with HAb18G/CD147 in human 7721 hepatoma cells. The enhancing effect of HAb18G/CD147
on adhesion, invasion capacities and matrix metalloproteinases (MMPs) secretion was decreased by integrin α3β1 antibodies
(p<0.01). The expressions of integrin downstream molecules including focal adhesion kinase (FAK), phospho-FAK (p-FAK), paxillin,
and phospho-paxillin (p-paxillin) were increased in human hepatoma cells overexpressing HAb18G/CD147. Deletion of HAb18G/CD147
reduces the quantity of focal adhesions and rearranges cytoskeleton. Wortmannin and LY294002, specific phosphatidylinositol
kinase (PI3K) inhibitors, reversed the effect of HAb18G/CD147 on the regulation of intracellular Ca2+ mobilization, significantly reducing cell adhesion, invasion and MMPs secretion potential (p<0.01). Together, these results suggest that HAb18G/CD147 enhances the invasion and metastatic potentials of human hepatoma
cells via integrin α3β1-mediated FAK-paxillin and FAKPI3K-Ca2+ signal pathways.
Received 5 June 2008; received after revision 16 July 2008; accepted 23 July 2008 相似文献
9.
10.
11.
12.